Ibogaine Panel 14 Nov 2009

Posted by:

Ibogaine: Medical Practice, Science, and African Heritage

Date: 14th Nov. 2009

Time: 3.00pm-4.30pm

Location: International Drug Policy Reform Conference, Albuquerque, NM

The discovery of ibogaine’s use as an anti-addictive from the West
African plant, Tabernanthe iboga, has been principally championed by
drug user advocates in the United States, Canada, Brazil, Mexico, New
Zealand, Australia, Slovenia, Gabon and South Africa. Some scenes have
grown while others have declined. After decades of drug availability
suddenly supplies of ibogaine used in treatment was interrupted.
Botanical sources had to be found and manufacturing technologies
reevaluated by those skilled in the chemistry and manufacture. Amidst
all of these changes, the sharing of knowledge, cross cultural
understanding and the debt long owed to Africa was acknowledged
precipitating the organization of a Federation of Worldwide Ibogaine
Practitioners. This panel is that story.

Howard S. Lotsof, United States

Jeffrey Kamlet, MD, United States
Anwar Jeewa, South Africa
Dimitri Mobengo Mugianis, United States and Gabon
Clare Wilkins, Mexico and United States
Moughenda Mickala, Gabon and United States

For more information see: